226 related articles for article (PubMed ID: 15117921)
1. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
[TBL] [Abstract][Full Text] [Related]
2. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
3. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones.
del Valle LJ; Flores L; Vargas M; García-de-la-Guarda R; Quispe RL; Ibañez ZB; Alvarado D; Ramírez P; Ruiz J
Int J Infect Dis; 2010 Jun; 14(6):e506-10. PubMed ID: 19969497
[TBL] [Abstract][Full Text] [Related]
4. Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.
Sánchez-Céspedes J; Navia MM; Martínez R; Orden B; Millán R; Ruiz J; Vila J
J Clin Microbiol; 2003 Apr; 41(4):1769-71. PubMed ID: 12682183
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
6. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
7. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
[TBL] [Abstract][Full Text] [Related]
8. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone and multidrug resistance phenotypes associated with the overexpression of AcrAB and an orthologue of MarA in Yersinia enterocolitica.
Fàbrega A; Roca I; Vila J
Int J Med Microbiol; 2010 Nov; 300(7):457-63. PubMed ID: 20510648
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Su X; Lind I
Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
[TBL] [Abstract][Full Text] [Related]
11. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains.
Laatu M; Rautelin H; Hänninen ML
J Antimicrob Chemother; 2005 Feb; 55(2):182-7. PubMed ID: 15649999
[TBL] [Abstract][Full Text] [Related]
14. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
[TBL] [Abstract][Full Text] [Related]
15. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
16. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Levy DD; Sharma B; Cebula TA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
18. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains.
Valdezate S; Vindel A; Saéz-Nieto JA; Baquero F; Cantón R
J Antimicrob Chemother; 2005 Jul; 56(1):220-3. PubMed ID: 15928010
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
20. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.
Lascols C; Robert J; Cattoir V; Bébéar C; Cavallo JD; Podglajen I; Ploy MC; Bonnet R; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):402-9. PubMed ID: 17254753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
